JMP Securities Sticks to Their Buy Rating for Cytokinetics (CYTK)
JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.
news.stocktradersdaily1d
(JPST) Pivots Trading Plans and Risk Controls
This Jpmorgan Ultra-short Income Etf (NASDAQ: JPST) report was produced by Stock Traders Daily. Over the past 20 years our metholdology has been refined to help identify strategies for both individual ...
JMP Securities Reaffirms Their Buy Rating on Kemper (KMPR)
JMP Securities analyst Matthew Carletti reiterated a Buy rating on Kemper (KMPR – Research Report) today and set a price target of $85.00. The ...
JFK Millennium Partners Announces RFPs for Guest Services, Security, and Maintenance/Janitorial Services ahead of 2026 JFK Terminal 6 Opening
JFK Millennium Partners (JMP), the company selected by the Port Authority of New York & New Jersey (PANYNJ) to build and ...